Learn database normalization through this tutorial that covers key concepts and processes of 1NF, 2NF, and 3NF. Discover ...
Across 76 weeks in obesity/overweight without type 2 diabetes, survodutide achieved up to 16.6% mean weight loss versus 3.2% ...
ODDITY Tech Ltd. (NASDAQ: ODD) today announced its financial results for the first quarter ended March 31, 2026. “We continue to implement our recovery plan to address the account dislocation with our ...
IQIRVO® data expands scientific evidence in fatigue, showing clinically meaningful improvements in patients with ...
Combination tobevibart 300 mg + elebsiran 200 mg q4w achieved HDV RNA TND in 77% at week 72 and 88% at week 96, outperforming tobevibart monotherapy. Profound HBsAg lowering occurred with dual therapy ...
Mizuho Technology Conference 2026 June 9, 2026 2:35 PM EDTCompany ParticipantsPatrick Stokes - President & Chief ...
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat ...
Philstar.com on MSN
OFW remittances continue to climb
Despite global uncertainties MANILA, Philippines — Cash remittances from overseas Filipinos continued to post modest growth in March, supporting household spending and the Philippine economy despite ...
US FDA grants accelerated approval to Gilead’s Hepcludex for the treatment of chronic hepatitis delta virus: Foster City, California Tuesday, May 26, 2026, 10:00 Hrs [IST] Gilea ...
US businesses are brushing off those “Now Hiring” signs: Job openings rose sharply in April to their highest level in nearly ...
Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 9:20 AM EDTCompany ParticipantsBrian Scott ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results